USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: AERIS THERAPEUTICS, INC.
Address: AERIS THERAPEUTICS, INC.
10K GILL ST
WOBURN, MA 01801 0172
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: (781) 937-0110

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $195,000.00 2
SBIR Phase II $855,484.00 1

Award List:

Pneumedoreductive Surfacant - New Therapy for Emphysema

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Edward P. Ingenito
Award Amount: $95,000.00
Abstract:
DESCRIPTION (provided by applicant): This Phase I SBIR application is presented by Bistech, Inc. of Woburn, MA. It will test the feasibility of using a new inhaled pharmaceutical agent, pneumoreductive surfactant (PRS), to treat pulmonary emphysema, a progressive and disabling disease that affects… More

Enzymatic Pleurodesis for Malignant Pleural Effusions

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Larry W. Tsai
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): This Phase I SBIR application is presented by Aeris Therapeutics, Inc. of Woburn, MA. It will examine the feasibility of using a novel enzyme based-system to produce safe, clinically-effective pleurodesis for treatment of malignant pleural effusions.… More

Pneumoreductive Surfactant Therapy for Emphysema

Award Year / Program / Phase: 2006 / SBIR / Phase II
Agency: HHS
Principal Investigator: Edward P. Ingenito
Award Amount: $855,484.00
Abstract:
DESCRIPTION (provided by applicant): Aeris therapeutics is developing a novel medical treatment for patients with advanced emphysema known as Pneumoreductive Surfactant (PRS). PRSs are inhaled drugs that increase lung recoil by safely altering the surface tension properties of native lung… More